Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Hua Medicine ( (HK:2552) ) has provided an update.
Hua Medicine has announced that its board of directors will meet on August 28, 2025, to consider and approve the interim results for the first half of the year ending June 30, 2025. This meeting is significant as it will determine the company’s financial performance and potentially impact its market positioning and stakeholder confidence.
More about Hua Medicine
Hua Medicine is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It focuses on developing innovative therapies and is publicly listed on the Hong Kong Stock Exchange.
YTD Price Performance: 139.04%
Average Trading Volume: 9,966,170
Technical Sentiment Signal: Buy
Current Market Cap: HK$3.39B
See more data about 2552 stock on TipRanks’ Stock Analysis page.